Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › State College › NPI 1730173154
Clinic

Mount Nittany Medical Center

Mount Nittany Medical Center was paid $4.32M by Medicaid between Jan 2018 and Dec 2024, across 216 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoMOUNT NITTANY MEDICAL CENTER
STATE COLLEGE, PA 16803
33aNPI1730173154assigned 08/31/2005
33bProvider typeClinic/Center
28Total paid$4.32M
24GClaims181,091
24DCodes billed216
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in Pennsylvania

Rank by total paid#35 of 176
Median peer was paid$441K
This provider vs. median9.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201839$7K
201950$1K
202019,223$423K
202192,638$2.32M
202224,213$556K
202325,451$588K
2024incomplete19,477$429K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 14,278 13,873 $975K
G0378 Hospital observation service, per hour 9.3% 337 320 $404K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.2% 3,542 3,407 $313K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.2% 3,664 3,526 $309K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.5% 7,126 6,964 $281K
80053 Comprehensive metabolic panel 4.1% 16,525 15,529 $177K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.7% 1,036 1,000 $161K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.3% 1,252 1,190 $141K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.9% 4,775 4,551 $126K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 19,284 17,809 $101K
70450 Computed tomography, head or brain; without contrast material 1.6% 1,233 1,182 $71K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 6,914 6,550 $62K
204 more codes
96375 Therapeutic injection; each additional sequential IV push 1.4% 3,326 $60K
71275 Computed tomographic angiography, chest, with contrast material 1.3% 318 $54K
T1015 A visit at a community health center or clinic (one all-in rate) 1.1% 894 $48K
84443 Thyroid stimulating hormone (TSH) 1.1% 2,544 $48K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 836 $47K
71045 Radiologic examination, chest; single view <1% 5,405 $38K
80050 General health panel <1% 792 $37K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,263 $35K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 143 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,076 $30K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 776 $29K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 410 $29K
84484 <1% 3,088 $26K
80061 Lipid panel <1% 1,855 $24K
83690 <1% 5,112 $23K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,509 $22K
86618 <1% 468 $21K
77067 Screening mammography, bilateral, including computer-aided detection <1% 242 $20K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 32 $20K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 542 $18K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 718 $17K
72125 Computed tomography, cervical spine; without contrast material <1% 270 $16K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,990 $14K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 156 $14K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 593 $14K
93971 <1% 229 $14K
80048 Basic metabolic panel (calcium, ionized) <1% 2,082 $14K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 585 $14K
97597 <1% 911 $13K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 108 $13K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 358 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 275 $11K
83735 <1% 2,044 $11K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 13 $9K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 182 $9K
81001 <1% 3,343 $9K
84703 <1% 933 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 1,330 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 276 $8K
82077 <1% 272 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 541 $7K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 183 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 730 $7K
87634 <1% 95 $7K
450 Pov group 1 hd 301-450 lbs <1% 19 $6K
76830 Ultrasound, transvaginal <1% 140 $6K
87088 <1% 751 $6K
85610 <1% 1,898 $6K
71250 <1% 107 $6K
80143 <1% 218 $6K
84702 <1% 358 $6K
71046 Radiologic examination, chest; 2 views <1% 529 $6K
80179 <1% 212 $6K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 86 $6K
76770 <1% 140 $5K
82607 <1% 406 $5K
74018 <1% 483 $5K
73610 <1% 311 $5K
81003 <1% 1,837 $5K
84439 <1% 679 $5K
96361 Intravenous infusion, hydration; each additional hour <1% 479 $5K
87186 <1% 637 $4K
82728 <1% 403 $4K
88342 <1% 147 $4K
83970 <1% 116 $4K
0001A <1% 96 $4K
85378 <1% 471 $4K
85027 <1% 715 $4K
87040 <1% 271 $4K
81025 <1% 1,152 $4K
73630 <1% 378 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 147 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 169 $4K
83880 <1% 152 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 16 $3K
86885 <1% 531 $3K
82784 <1% 145 $3K
87340 <1% 215 $3K
73030 <1% 231 $3K
86762 <1% 159 $3K
87070 <1% 598 $3K
76642 <1% 76 $3K
82950 <1% 417 $3K
80076 <1% 353 $3K
70486 <1% 43 $3K
73562 <1% 189 $3K
86617 <1% 62 $3K
83540 <1% 334 $3K
86803 <1% 128 $2K
87077 <1% 351 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 59 $2K
82570 <1% 349 $2K
70496 <1% 14 $2K
80349 <1% 169 $2K
84153 <1% 86 $2K
85730 <1% 569 $2K
0002A <1% 46 $2K
96367 <1% 153 $2K
82043 <1% 252 $2K
86901 <1% 562 $2K
86900 <1% 561 $2K
84145 <1% 144 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 237 $2K
94664 <1% 206 $2K
82550 <1% 333 $2K
76536 <1% 38 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $2K
84100 <1% 374 $2K
73130 <1% 160 $2K
86038 <1% 96 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 57 $1K
73560 <1% 113 $1K
85652 <1% 546 $1K
29515 <1% 50 $1K
0003A <1% 32 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,525 $1K
83605 <1% 266 $1K
74022 <1% 73 $1K
73110 <1% 133 $1K
86592 <1% 305 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 33 $1K
72110 <1% 60 $1K
86140 <1% 486 $1K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 72 $1K
73502 <1% 77 $1K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 26 $1K
12001 <1% 44 $1K
82248 <1% 198 $1K
82962 <1% 804 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 584 $938.33
70491 <1% 13 $923.85
12011 <1% 12 $851.11
90715 <1% 40 $775.58
36415 Collection of venous blood by venipuncture <1% 1,564 $765.07
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,605 $758.74
72131 <1% 13 $715.81
J2704 Injection, propofol, 10 mg <1% 2,058 $709.12
85018 <1% 243 $708.58
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 32 $695.24
85014 <1% 236 $683.85
84146 <1% 26 $671.28
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 67 $658.00
87081 <1% 125 $656.93
83550 <1% 128 $612.19
J0780 Injection, prochlorperazine, up to 10 mg <1% 169 $600.26
73590 <1% 41 $571.29
87427 <1% 42 $569.18
96376 <1% 114 $563.76
J3490 Unclassified drugs <1% 342 $555.95
87075 <1% 78 $552.79
83615 <1% 95 $545.07
80069 <1% 58 $525.28
97598 <1% 25 $508.48
84481 <1% 26 $501.61
84460 <1% 77 $490.77
86308 <1% 65 $444.05
82010 <1% 111 $394.50
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 570 $388.46
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,220 $380.82
80164 <1% 27 $357.02
82565 <1% 75 $349.97
76801 <1% 12 $334.38
84403 <1% 12 $328.59
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,329 $322.47
84466 <1% 26 $318.75
84550 <1% 58 $313.29
72100 <1% 16 $299.19
J0690 Injection, cefazolin sodium, 500 mg <1% 749 $294.34
82746 <1% 25 $281.64
J3475 Injection, magnesium sulfate, per 500 mg <1% 120 $275.70
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 33 $248.37
29125 <1% 14 $238.54
80047 <1% 25 $223.67
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 861 $221.93
73140 <1% 25 $216.15
80324 <1% 12 $208.84
84156 <1% 61 $207.11
83001 <1% 13 $199.43
J2060 Injection, lorazepam, 2 mg <1% 578 $164.05
87045 <1% 24 $161.28
86431 <1% 18 $155.97
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,802 $151.10
87207 <1% 37 $140.18
73080 <1% 16 $115.58
J2550 Injection, promethazine hcl, up to 50 mg <1% 81 $105.42
86376 <1% 13 $90.83
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,783 $70.38
S0028 Injection, famotidine, 20 mg <1% 15 $70.20
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 152 $62.78
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 32 $61.44
87046 <1% 24 $60.99
82947 <1% 16 $53.80
81002 <1% 16 $51.64
88304 <1% 15 $47.63
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 142 $32.65
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 18 $14.32
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 38 $7.65
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 111 $0.08
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 195 $0.00
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 0% 96 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 69 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 14 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROACH, BRYAN (CFO)
Same official

Other billing entities under ROACH, BRYAN

Full network →
ProviderLocationPaid
Mount Nittany Medical Center Health Services INCState College, PA$536K
Mount Nittany Medical CenterState College, PA$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.